WEEKLY e-ALERT  [ PREMIUM EDITION ]
Pharma China (www.pharmachinaonline.com) is the most influential English media and source of business intelligence covering the Chinese pharmaceutical sector. Pharma China caters for the growing needs of the international pharmaceutical industry for up-to-date and insightful information and intelligence on China’s burgeoning but increasingly complex healthcare marketplace, and is subscribed by most MNC pharma companies, leading CROs, investment banks, consulting firms active in China as well as relevant industry associations and government agencies.

Note: To view full text of free articles, you need to register as a basic member first and then log in. To view premium articles, you need to subscribe to Pharma China as a premium member. For more information or subscription, please contact info@pharmachinaonline.com. If you wish to unsubscribe from this e-Alert, please reply this e-mail with "Remove" in the subject line.
Industry News
CDE Publicizes 18 Drug Applications To Be Granted Priority Review Status(9/16/2019 )  (Premium)
  The CDE publicized on September 12 and 16 respectively 18 more drug applications which are to be granted priority review status. All of these applications are from 12 domestic pharmaceutical companies.
Helsinn and Mundipharma Announce Chinese Approval of Akynzeo Oral Formulation(9/16/2019 )  (free)
  Helsinn and Mundipharma China Pharma jointly announced on September 16 that the NMPA has approved the oral formulation of Akynzeo for the treatment of chemotherapy-induced nausea and vomiting (CINV) in China.
Regulatory News
NMPA Publicizes List of Reference Formulations for Generic Drug Equivalence Studies (24th Batch)(9/16/2019 )  (Premium)
  The NMPA publicizes on September 16 the List of Reference Formulations for Generic Drug Quality and Efficacy Studies (24th Batch). The publication period is between September 16 and 27 (ten working days). The 24th batch of the List is composed of 211 reference drug products.
General Health
China to Raise BMI Reimbursement of Outpatient Diabetes and Hypertension Drugs to Above 50%(9/16/2019 )  (Premium)
  Premier LI Keqiang chaired an executive meeting of the State Council on September 11. The meeting decided to raise the BMI outpatient drug reimbursement of hypertension and diabetes patients.
China Begins Mapping Standards for 5G-based Hospitals(9/16/2019 )  (Premium)
  Key Chinese hospitals, leading telecom carriers and Huawei launched a project to establish standards for 5G-based networks in hospitals on September 6. The project is under the guidance of the NHC and led by the China-Japan Friendship Hospital.
China Sees Rising Number of Nurses(9/16/2019 )  (free)
  Since the end of 2018, the number of China's registered nursing staff has risen to more than 4 million compared with 30,000 in the early 1950s, an official with the National Health Commission said on September 13.
© Wicon International GroupˇˇSupport by: www.heightow.com Home | Site map | Contact Us | Links